Sirolimus trials for Sickle cell disease

All Sirolimus trials · All Sickle cell disease trials

Phase breakdown

Recruiting trials studying Sirolimus for Sickle cell disease

• 131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
  NCT07015684 · Phase: Phase 1 · Ages: 12 Years to 50 Years · Sex: All (male and female) · 1 location
• Allo HSCT for High Risk Hemoglobinopathies
  NCT06872333 · Phase: Phase 2 · Ages: Up to 55 Years · Sex: All (male and female) · 1 location
• Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
  NCT07616154 · Phase: Phase 2 · Ages: Up to 22 Years · Sex: All (male and female) · 1 location
• Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor
  NCT03214354 · Phase: Phase 2 · Ages: 1 Year to 19 Years · Sex: All (male and female) · 1 location
• Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
  NCT06358638 · Phase: Phase 2 · Ages: 2 Years to 25 Years · Sex: All (male and female) · 1 location
• Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
  NCT03121001 · Phase: Phase 2 · Ages: 16 Years to 60 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Sirolimus for Sickle cell disease?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.